Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Wegovy News
Top stories
Novo Nordisk's Wegovy Weight-Loss Drug Approved in China, Shares Rise 1.8% Pre-Market
Authors
19
5 days
China
Economics
World
Study Finds Saxenda and Ozempic Pose Bone Health and Density Risks Amid Global Drug Shortages; $NVO, $LLY Affected
Authors
8
4 days
Economics
Health
World
New Wave of Weight Loss Drugs to Burn More Fat and Improve Health
Authors
8
6 days
Economics
Health
Politics
Zealand Pharma's High Dose Obesity Drug Reduces Weight by 8.6%, Shares Surge 17%-23%
Authors
11
9 days
Bio
Science
House Panel Considers Expanding Medicare Coverage for Cancer Screening, Wegovy, and Blood Tests
Authors
4
9 days
Bio
Science
Demand for Ozempic, Wegovy Pushes Indians to Gray Markets; Prices Less Than 10% of U.S.
Authors
36
10 days
China
Economics
World
NHS Urges Boots, Superdrug to Halt Online Wegovy Sales Without Checks
Authors
4
10 days
Britain
World
Ozempic Users Spend $50 Billion on Weight Loss Drugs, Buy Smaller Clothes
Authors
16
11 days
Economics
Business
Doctors Warn Against Ozempic Misuse Amid Jesse Plemons Denial and Muscle Loss Concerns
Authors
18
13 days
Culture
Bernie Sanders Calls for Subpoena Over Novo Nordisk CEO on Ozempic, Wegovy Pricing
Authors
9
16 days
Bio
Science
Prediction markets for Wegovy
Prediction markets for Wegovy
The FDA will warn about overuse or misuse of semaglutide (Ozempic, Wegovy and Rybelsus) before the end of 2024.
Oct 19, 12:59 PM
Jan 1, 3:59 PM
27.41%
chance
22
932
Option
Votes
YES
NO
1098
930
Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss
Feb 7, 1:31 AM
Jan 1, 7:59 AM
69.99%
chance
26
1303
Option
Votes
NO
YES
1396
718
Will Wegovy top 20 billion DKK in sales in 2024 quarter?
Jan 7, 6:09 PM
Feb 1, 7:59 AM
13.72%
chance
5
193
Option
Votes
YES
NO
255
57
[1000M subsidy] What will have been the most important thing to happen in 2024?
Nov 10, 2:28 PM
Jan 10, 10:59 PM
35
2349
What will John Oliver talk about on his show? [Mega Market]
Apr 15, 4:24 AM
Jan 1, 7:59 AM
21
3339
Before 2033, will semaglutide be shown to improve lifespan, when prescribed to overweight people?
May 27, 3:00 AM
Jan 2, 4:59 AM
89.87%
chance
19
3235
Option
Votes
NO
YES
2251
742
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
Dec 8, 8:59 AM
Jan 1, 11:59 PM
67.74%
chance
15
710
Option
Votes
YES
NO
993
984
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
Mar 8, 4:50 PM
Dec 31, 10:59 PM
30.27%
chance
24
1255
Option
Votes
YES
NO
1185
849
Will Semaglutide cost less than $2000 per year before 2031?
Jun 2, 7:29 PM
Mar 5, 10:59 PM
88.46%
chance
20
3363
Option
Votes
NO
YES
2769
361
Will Semaglutide cost less than $1000 per year before 2031?
Jun 21, 11:59 AM
Mar 5, 10:59 PM
73.48%
chance
2
110
Option
Votes
NO
YES
166
60
[ACX 2024] Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?
Jan 1, 1:31 PM
Jan 2, 6:00 PM
2.53%
chance
48
3696
Option
Votes
YES
NO
2586
895
Will Semaglutide cost less than $1000 per year before 2030?
Jun 24, 11:20 AM
Mar 5, 10:59 PM
73.58%
chance
3
85
Option
Votes
NO
YES
167
60
Articles
Latest stories
Study Finds Saxenda and Ozempic Pose Bone Health and Density Risks Amid Global Drug Shortages; $NVO, $LLY Affected
Authors
8
4 days
Economics
Health
World
Novo Nordisk's Wegovy Weight-Loss Drug Approved in China, Shares Rise 1.8% Pre-Market
Authors
19
5 days
China
Economics
World
New Wave of Weight Loss Drugs to Burn More Fat and Improve Health
Authors
8
6 days
Economics
Health
Politics
House Panel Considers Expanding Medicare Coverage for Cancer Screening, Wegovy, and Blood Tests
Authors
4
9 days
Bio
Science
Zealand Pharma's High Dose Obesity Drug Reduces Weight by 8.6%, Shares Surge 17%-23%
Authors
11
9 days
Bio
Science
Zealand Pharma Reports Positive Results from Phase 1b Obesity Drug Trial, 8.6% Weight Loss
Authors
5
10 days
Bio
Science
Demand for Ozempic, Wegovy Pushes Indians to Gray Markets; Prices Less Than 10% of U.S.
Authors
36
10 days
China
Economics
World
NHS Urges Boots, Superdrug to Halt Online Wegovy Sales Without Checks
Authors
4
10 days
Britain
World
Wealthy Indians Turn to Gray Market for Ozempic and Wegovy
Authors
14
11 days
Britain
World
Ozempic Users Spend $50 Billion on Weight Loss Drugs, Buy Smaller Clothes
Authors
16
11 days
Economics
Business
Americans Spent $50 Billion on Ozempic and Wegovy, GLP-1 Medicines Evolve to Address Health Conditions Beyond Weight Loss
Authors
13
11 days
Economics
Business
Doctors Warn Against Ozempic Misuse Amid Jesse Plemons Denial and Muscle Loss Concerns
Authors
18
13 days
Culture
Bernie Sanders Calls for Subpoena Over Novo Nordisk CEO on Ozempic, Wegovy Pricing
Authors
9
16 days
Bio
Science
Michigan's Largest Insurer to Drop GLP-1 Obesity Drugs Coverage Starting January
Authors
13
18 days
Economics
Business
Eli Lilly to Release orforglipron Data in April 2025 Amid Global Shortages and New Syntis Bio Approach in Obesity Treatment
Authors
19
19 days
Economics
Business
Bob Langer's Syntis Bio Raises $290M to Develop GLP-1 Obesity Treatments
Authors
6
19 days
Bio
Science
Eli Lilly and Novo Nordisk's Weight-Loss Drugs Revolutionize Obesity Treatment and Economy
Authors
11
20 days
Economics
Business
Wegovy, Mounjaro, Ozempic: Weight Loss Drugs Gain Popularity, Spark Debates
Authors
5
23 days
Bio
Science
Novo Nordisk Faces Competition in China from 15 Generic Versions for Ozempic and Wegovy
Authors
10
24 days
China
Economics
World
UK Regulator Recommends Free Eli Lilly's Mounjaro for Weight Loss on Better Terms
Authors
4
26 days
Bio
Science
Ozempic's Popularity Spurs FDA Warning, Shortages, Counterfeits, and Generic Competition
Authors
31
26 days
China
Economics
World
Studies Highlight Efficacy of Tirzepatide and Semaglutide in Health Outcomes
Authors
9
28 days
China
Bio
World
Ozempic and Wegovy Raise Safety Concerns Amid $130 Billion Market Growth and Unexpected Pregnancies
Authors
10
28 days
Tech
Ozempic and Wegovy Gain Popularity for Weight Loss, Potential Kidney Disease Treatment and Side Effects
Authors
15
29 days
Culture
Novo Nordisk Sues Multiple U.S. Companies Over Semaglutide Marketing
Authors
8
1 month
Bio
Science
Novo Nordisk Ramps Up Ozempic Production, Sues Over False Claims Amid Sugar Industry Impact
Authors
9
1 month
Economics
Business
Ro Launches GLP-1 Supply Tracker for Ozempic and Wegovy Shortages
Authors
25
1 month
Economics
Business
Telehealth Company Ro Launches Free Tool to Track Ozempic, Wegovy Shortages
Authors
6
1 month
Economics
Business
Novo Nordisk, Eli Lilly drive weight-loss drug market to $150 billion by early 2030s
Authors
15
1 month
Economics
Business
Novo Nordisk Retains 60% Price of Ozempic and Wegovy in US Amid Doctor Shortage and Affordability Concerns
Authors
28
1 month
Economics
Business
Novo Nordisk's Ozempic and Wegovy Drive Weight Loss, Economic Growth, and Renal Benefits
Authors
31
1 month
Economics
Business
Ozempic and Wegovy Reduce Major Kidney Disease Events by 24% in People with Diabetes
Authors
29
1 month
Bio
Science
15.5M U.S. adults use Ozempic, Wegovy for weight loss; GLP-1 agonists' Breakthrough of the Year, physicians note
Authors
10
1 month
Bio
Science
Novo Nordisk's Ozempic and Wegovy Reduce Kidney-Related Events, Show Promise for Chronic Kidney Disease and Alcoholism
Authors
9
1 month
Bio
Science
Novo Nordisk's Wegovy Reduces Kidney Events by 22%; New Ozempic Rival Drug Trials in Melbourne
Authors
12
1 month
Health
Science
Semaglutide Shows Impressive Results in Kidney Disease, Lilly and Novo Nordisk to Dominate GLP-1 Drug Market with IL7 SNP Association and Teclistamab Resistance at ASCO Annual Meeting
Authors
47
1 month
Bio
Science
Novo Nordisk's Semaglutide Shows Significant Health Benefits in FLOW Trial for Kidney Disease
Authors
29
1 month
Bio
Science
Use of Weight-Loss Drugs Among Youth Soars 600% Since 2020 Amid Uncertainty Over Long-Term Effects
Authors
33
1 month
Bio
Science
GLP-1 Weight-Loss Drug Use Surges 600% Among US Adolescents and Young Adults
Authors
17
1 month
Science
Study Reveals Surge in GLP-1RA, Ozempic, and Wegovy Prescriptions Among Adolescents and Young Adults
Authors
5
1 month
Bio
Science
Promising Results in Weight-Loss Drugs Research and Trials, Including Ozempic 2.0 and Novo Nordisk
Authors
39
1 month
Culture
$5 Zyn Nicotine Pouches and New Entrants Shake Up Weight-Loss Drug Market
Authors
18
1 month
Economics
Business
Novo Nordisk's Wegovy Revenue Estimate and Impact on US Healthcare Systems and Drug Spending
Authors
22
1 month
Health
Science
Studies Show 10% Weight Loss with Ozempic and Wegovy, New GLP-1 and NMDA Treatments Explored
Authors
28
1 month
Culture
High-Priced Wegovy Could Bankrupt U.S. Healthcare System, $1 Trillion Annual Cost Warned
Authors
7
1 month
Health
Science
Wegovy Users Maintain 10% Weight Loss for 4 Years, GLP-1 and NMDA Combo Shows Promise - Novo Nordisk
Authors
19
1 month
Culture
Sanders warns Wegovy impact, Roche's CT-388 excels with 18.8% weight loss, $400M into obesity biotech
Authors
36
1 month
China
Bio
World
Roche's CT-388 Shows Positive Results in Obesity Trial
Authors
36
2 months
Bio
Science
Novo Nordisk's Wegovy: Cardio Benefits Not Weight-Dependent; $22.5B Revenue by 2030, $400B Cost Concerns Sanders
Authors
9
2 months
Bio
Science
Debate Over Wegovy and Ozempic Effectiveness in Combating Obesity and Heart Disease
Authors
9
2 months
Britain
World
Semaglutide Study Shows 20% Heart Risk Reduction and Significant Weight Loss Benefits in Non-Diabetic Adults with Overweight
Authors
17
2 months
Health
Science
Weight-Loss Drugs: Efficacy and Side Effects Under Scrutiny Amid Price Criticism
Authors
37
2 months
Economics
Business
12% of U.S. Adults Use GLP-1 Drugs Like Ozempic for Chronic Conditions, KFF Survey Finds
Authors
6
2 months
Economics
Business
Eli Lilly Develops New Weight-Loss Pill, Orforglipron; Cipla Eyes Partnership for India Market
Authors
18
2 months
Economics
Business
Wegovy Launches in Israel; Concerns Over Serious Side Effects, Pregnancy Risks
Authors
14
2 months
Israel
Health
Crime
Amgen's MariTide Obesity Drug Phase 2 Test Results Remain Confidential Amid Analyst Speculation
Authors
7
2 months
Economics
Crime
Business
Amgen's MariTide Moves to Phase 3, Shares Surge 13%
Authors
25
2 months
Economics
Crime
Business
Ozempic Boom Spurs Store Redesigns, Faces Scrutiny Over $1,000/Month Cost and Health Risks
Authors
21
2 months
Crime
Culture
Weight-loss drug Wegovy available in Canada amid Ozempic controversies and legal charges
Authors
15
2 months
Canada
Crime
World
Novo Nordisk Q1 Sales Hit DKK 65.35B, EBIT DKK 31.85B; FY Growth Forecast 19%-27%
Authors
43
2 months
Economics
Crime
Business
Weight-loss drug Wegovy expands availability from Britain to Canada and Israel, supply shortages ease
Authors
7
2 months
Israel
Canada
Crime
Novo Nordisk Raises 2024 Outlook, $6.4B Investment as Wegovy Sales Surge Amid Eli Lilly Competition
Authors
18
2 months
Economics
Crime
Business
Novo Nordisk's Market Cap Surpasses Danish Economy; Profits Soar Above Q1 Forecast with Wegovy and Ozempic Sales
Authors
30
2 months
Economics
Crime
Business
Shell Surpasses Q1 Profit Estimates, Announces $3.5B Buyback; Novo Sales Exceed Forecasts
Authors
5
2 months
Economics
Business
Denmark Cuts Ozempic Subsidies as Novo Nordisk Value Soars, Ramps Up Wegovy Production
Authors
24
2 months
Economics
Crime
Business
Novo Nordisk Raises 2024 Outlook, Wegovy Prescriptions Hit 130,000 Amid Eli Lilly Rivalry
Authors
21
2 months
Economics
Crime
Business
Weight loss drugs reshape industry, Jon Gosselin credits Ozempic for 30-pound weight loss despite side effects and high cost
Authors
34
2 months
Culture
Ozempic's Impact on Celebrities, Users, and Senate Scrutiny Revealed
Authors
19
2 months
Crime
Culture
Weight Loss Drugs Ozempic and Wegovy Spark Industry Disruption, Research Challenges, and Concerns Over Costs and Side Effects
Authors
25
2 months
Health
Science
Ozempic, Wegovy Sales Surge; Costs May Reach $1 Trillion Annually
Authors
14
2 months
Bio
Science
Ozempic Shortages Prompt 1,000 Mile Searches; Sen. Sanders Investigates Pricing
Authors
22
2 months
Bio
Crime
Science
Sen. Sanders Probes Novo Nordisk as GLP-1 Drug Spending Surges
Authors
11
2 months
Bio
Crime
Science
3.6 Million Medicare Beneficiaries Eligible for Wegovy Coverage After FDA Approval
Authors
6
2 months
Economics
Business
Ozempic linked to surprise pregnancies, birth defects; reshaping health industry; cost concerns; side effects, shortage, users traveling
Authors
19
2 months
Crime
Culture
Novo Nordisk Sees Growth with Ozempic and Wegovy, Faces Concerns Over Risks, Lean Muscle Effects, and Advocacy Against Bias
Authors
12
2 months
Economics
Business
GLP-1 Receptor Agonists Ozempic, Wegovy, Mounjaro, and Zepbound Gain Popularity Amid Concerns Over Disclosure and Risks
Authors
8
2 months
Bio
Science
Studies Highlight Effectiveness of Semaglutide in Heart Failure and Type 2 Diabetes Amid Growing Attention on New Weight-Loss Drugs and Potential Risks
Authors
35
2 months
Health
Science
EU Regulators: No Suicide Link to Ozempic, Wegovy; FDA, British Health Authorities Agree
Authors
22
3 months
Bio
Crime
Science
EU and FDA Find No Suicide Risk in Wegovy After Nine-Month Probe
Authors
28
3 months
Economics
Crime
Business
Indian pharma giants pivot to weight-loss drugs; Ozempic linked to MS risk reduction, sleep apnea aid, and over 100 US deaths
Authors
7
3 months
Crime
Culture
Wegovy Aids HFpEF and Diabetes Patients Beyond Weight Loss
Authors
8
3 months
Bio
Crime
Science
Wegovy Effective in Heart Failure Treatment: STEP-HFpEF DM Trial Results
Authors
14
3 months
Bio
Crime
Science
Costco Offers U.S. Members Discounted Weight Loss Programs with Ozempic, Wegovy
Authors
10
3 months
Politics
Airfinity Data: Wegovy Prevents Chronic Kidney Disease, Mixed Results in Heart Failure Trials with empagliflozin and CSL112
Authors
17
3 months
Bio
Crime
Science
Weight-loss drugs Ozempic and Wegovy under scrutiny for lawsuits, low blood sugar, cancer risks, and more
Authors
19
3 months
Culture
Novo Nordisk, Eli Lilly See Surge in GLP-1 Drug Sales as 'Ozempic' Popularity Rises; Medicare's Wegovy Coverage Affects Premiums
Authors
47
3 months
Economics
Crime
Business
Insurers Cover Wegovy for Medicare Recipients With Heart Conditions, Premium Concerns Rise
Authors
9
3 months
Politics
Weight-Loss Drug Shortages Spark $1.50 Hot Dog Crackdown at Costco Amid Surge in Obesity Drugs, Clinical Trials, and Nationwide Shortages
Authors
38
3 months
Economics
Business
Celebrity Rebel Wilson Tries Ozempic for Weight Loss Amid Trainer's Criticism of Dangerous Trend
Authors
24
3 months
Crime
Culture
Novo Nordisk Surpasses Tesla in Market Value with Weight Loss Drug Success
Authors
7
3 months
Economics
Business
Novo Nordisk's Wegovy eclipses Tesla with positive trial results; GLP-1 drugs spark national conversation on obesity
Authors
10
3 months
Economics
Business
Medicare Spending on GLP1s Soars to $5.7 Billion, Generics Cheaper Than Ozempic, Impacting Aspiration Risk, Food Preference, Bariatric Surgery
Authors
7
3 months
Health
Science
Weight Loss Drugs Linked to 'Ozempic Babies' Cause Nationwide Shortages of Ozempic
Authors
11
3 months
Culture
Rise of 'Ozempic babies' as Women Get Pregnant While on Weight Loss Drugs, Including Mounjaro, Raising Concerns About Interference with Birth Control
Authors
8
3 months
Politics
Nationwide Surge in 'Ozempic babies' as Weight Loss Drugs Lead to Unexpected Pregnancies
Authors
11
3 months
Culture
FDA Unapproved 'Ozempic Babies' Amid Unexpected Pregnancies with Wegovy
Authors
11
3 months
Economics
Business
Concerns Rise Over 'Ozempic Babies' Pregnancy Risk for Women from Weight-Loss Drugs
Authors
9
3 months
Culture
U.S. Health Insurers, Including CVS, Elevance, Kaiser Permanente, to Cover Novo Nordisk's Wegovy for Medicare Beneficiaries
Authors
6
3 months
Economics
Business
Obesity drugs Ozempic and Wegovy reshaping science, healthcare landscape with side effects and shortages
Authors
34
3 months
Culture
Obesity Drugs Sales Surge as Wegovy and Zepbound Gain Popularity
Authors
7
3 months
Economics
Business
Previous
Next
